Cargando…
Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin‐mediated phosphoinositide 3‐kinase/Akt/mammalian target of rapamycin
Bone marrow mesenchymal stem cells (BMMSC) have been shown to be recruited to the tumor microenvironment and exert a tumor‐promoting effect in a variety of cancers. However, the molecular mechanisms related to the tumor‐promoting effect of BMMSC on head and neck cancer (HNC) are not clear. In this s...
Autores principales: | Liu, Chuanxia, Feng, Xiaoxia, Wang, Baixiang, Wang, Xinhua, Wang, Chaowei, Yu, Mengfei, Cao, Guifen, Wang, Huiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834805/ https://www.ncbi.nlm.nih.gov/pubmed/29284199 http://dx.doi.org/10.1111/cas.13479 |
Ejemplares similares
-
Mammalian target of rapamycin and head and neck squamous cell carcinoma
por: Liao, Yu-Min, et al.
Publicado: (2011) -
Prognostic Significance of Periostin and Mammalian Target of Rapamycin (mTOR) in Locally Advanced Esophageal Squamous Cell Carcinoma
por: Jiang, Qi, et al.
Publicado: (2017) -
Periostin Directly and Indirectly Promotes Tumor Lymphangiogenesis of Head and Neck Cancer
por: Kudo, Yasusei, et al.
Publicado: (2012) -
TGFβ3-mediated induction of Periostin facilitates head and neck cancer growth and is associated with metastasis
por: Qin, Xing, et al.
Publicado: (2016) -
Omipalisib Inhibits Esophageal Squamous Cell Carcinoma Growth Through Inactivation of Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) and ERK Signaling
por: Zhu, Dong-shan, et al.
Publicado: (2020)